Carrie Brodmerkel
Overview
Explore the profile of Carrie Brodmerkel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
44
Citations
2461
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Argmann C, Hou R, Ungaro R, Irizar H, Al-Taie Z, Huang R, et al.
Gut
. 2022 Sep;
72(7):1271-1287.
PMID: 36109152
Objective: IBD therapies and treatments are evolving to deeper levels of remission. Molecular measures of disease may augment current endpoints including the potential for less invasive assessments. Design: Transcriptome analysis...
2.
Uzzan M, Martin J, Mesin L, Livanos A, Castro-Dopico T, Huang R, et al.
Nat Med
. 2022 Feb;
28(4):766-779.
PMID: 35190725
B cells, which are critical for intestinal homeostasis, remain understudied in ulcerative colitis (UC). In this study, we recruited three cohorts of patients with UC (primary cohort, n = 145;...
3.
DiNarzo A, Houten S, Kosoy R, Huang R, Vaz F, Hou R, et al.
Gastroenterology
. 2021 Nov;
162(3):828-843.e11.
PMID: 34780722
Background & Aims: Polygenic and environmental factors are underlying causes of inflammatory bowel disease (IBD). We hypothesized that integration of the genetic loci controlling a metabolite's abundance, with known IBD...
4.
Argmann C, Tokuyama M, Ungaro R, Huang R, Hou R, Gurunathan S, et al.
Gastroenterology
. 2021 Sep;
161(6):1953-1968.e15.
PMID: 34480882
Background And Aims: Disease extent varies in ulcerative colitis (UC) from proctitis to left-sided colitis to pancolitis and is a major prognostic factor. When the extent of UC is limited...
5.
Kosoy R, Kim-Schulze S, Rahman A, Friedman J, Huang R, Peters L, et al.
Cell Mol Gastroenterol Hepatol
. 2021 Apr;
12(2):599-632.
PMID: 33813036
Background: Inflammatory bowel disease (IBD) is a complex disease with variable presentation, progression, and response to therapies. Current disease classification is based on subjective clinical phenotypes. The peripheral blood immunophenome...
6.
Suarez-Farinas M, Tokuyama M, Wei G, Huang R, Livanos A, Jha D, et al.
Gastroenterology
. 2020 Sep;
160(1):287-301.e20.
PMID: 32980345
Background And Aims: The presence of gastrointestinal symptoms and high levels of viral RNA in the stool suggest active severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication within enterocytes. Methods:...
7.
Li K, Friedman J, Chan D, Pollack P, Yang F, Jacobstein D, et al.
Gastroenterology
. 2019 Jul;
157(4):1019-1031.e7.
PMID: 31279870
Background & Aims: Although ustekinumab is an effective therapy for moderate to severe Crohn's disease (CD), its effects on the microscopic manifestations of CD are unknown. Methods: We evaluated the...
8.
Li K, Strauss R, Marano C, Greenbaum L, Friedman J, Peyrin-Biroulet L, et al.
J Crohns Colitis
. 2019 Feb;
13(8):1025-1035.
PMID: 30721964
Background And Aims: Histologic evaluation is a meaningful complement to endoscopic and clinical measures in ulcerative colitis [UC]. There is a need for a definition of histologic improvement that can...
9.
Brodmerkel C, Li K, Garcet S, Hayden K, Chiricozzi A, Novitskaya I, et al.
J Allergy Clin Immunol
. 2019 Feb;
143(5):1965-1969.
PMID: 30703387
No abstract available.
10.
Contijoch E, Britton G, Yang C, Mogno I, Li Z, Ng R, et al.
Elife
. 2019 Jan;
8.
PMID: 30666957
Editorial Note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is...